Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Get the latest updates from What's new directly as they happen.
Follow now 334 followers
Last updated about 22 hours ago
about 22 hours ago
Human medicines European public assessment report (EPAR): Ondibta, insulin glargine, Date of...
about 23 hours ago
Human medicines European public assessment report (EPAR): Rimmyrah, ranibizumab, Date of authorisation...
about 23 hours ago
Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Date of authorisation...
about 23 hours ago
Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Date of authorisation...
about 23 hours ago
Human medicines European public assessment report (EPAR): Veoza, fezolinetant, Date of authorisation...
about 24 hours ago
Human medicines European public assessment report (EPAR): Tuyory, tocilizumab, Date of authorisation...
about 24 hours ago
Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation...
1 day ago
Orphan designation: chenodeoxycholic acid Treatment of inborn errors in primary bile acid...
1 day ago
Orphan designation: Icerguastat acetate Treatment of amyotrophic lateral sclerosis, 16/05/2022 Positive
1 day ago
Orphan designation: 2-(2-Chlorobenzylidene)hydrazinecarboximidamide acetate Treatment of Charcot-Marie-Tooth disease, 14/12/2015 Positive
1 day ago
Orphan designation: human anti-promyostatin monoclonal antibody (apitegromab) Treatment of spinal muscular atrophy...
1 day ago
Human medicines European public assessment report (EPAR): Rystiggo, rozanolixizumab, Date of authorisation...